The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director-General Tedros Adhanom Ghebreyesus mentioned on Monday.
Hydroxycholoroquine has been touted by Donald Trump and others as a potential remedy for the illness attributable to the Corona Virus. The U.S. president has mentioned he was taking the drug to assist forestall an infection.
“The govt group has carried out a brief pause of the hydroxychloroquine arm throughout the Solidarity trial whereas the safety knowledge is reviewed by the information safety monitoring board,” Tedros informed a web based briefing.
He mentioned the opposite arms of the trial – a serious worldwide initiative to maintain medical checks of potential remedies for the virus – had been persevering with.
The WHO has beforehand really useful towards utilizing hydroxychloroquine to deal with or forestall Corona Virus infections, besides as half of medical trials.
Dr. Mike Ryan, head of the WHO emergency program, mentioned the choice to droop trials of hydroxychloroquine had been taken out of “an abundance of warning.”